Eli Shobin
Company: Alzheimer's Drug Discovery
Job title: Senior Director, Head of the Diagnostics Accelerator
Seminars:
Patient Stratification for Precision Medicine In Neuroscience: How Can We Ensure The Right Patients Are Enrolled On The Right Drugs To Treat Their Specific Disease Pathology? 11:20 am
In a setting where our understanding of disease heterogeneity and subtyping in neuroscience is getting more clearly defined, the role of stratification biomarkers becomes more clearly crucial to clinical trial outcomes. Key Takeaways: Developing biomarkers has to go hand in hand with drug development to develop more sensitive tools to monitor function, cognition etc in…Read more
day: Pre-Conference Day AM Track C